Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

Pharmacists can help themselves in this era of PBMs by acting as educators. A patient with prescription benefits who is visiting a pharmacy may also be someone involved in the payer's decision ...

The markups helped the PBMs reap $7.3 billion from 2017 to 2022, the FTC found. The PBMs—owned by insurers Cigna, CVS Health and UnitedHealth Group—are supposed to help keep drug costs low for ...

Pharmacy benefit managers received substantial attention during 2024. Congress and regulating agencies including the FTC and HHS scrutinized PBM business practices and related profits. As a new ...

Legislators reached a bipartisan agreement to fund the federal government on Tuesday in a sweeping package that includes a number of important provisions for healthcare, including a two-year ...

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to ...

Outcomes Matter Innovations, LLC ("OMI") today announced the addition of seasoned healthcare executive, Paul Marchetti, to ...